The Hellenic PH created a new specialized clinical seminar “Time Matters When You Have PH” that was addressed to doctors of the main fields of medicine, pathology, cardiology, pneumology, intensive care, as well as the nursing staff. It is...
PH Doctor Stelios Orfanos talks about “Signaling pathways in Pulmonary Arterial Hypertension” PH Doctor Georgios Giannakoulas talks about ” Is there a need to treat more patients earlier?” PH Doctor Olivier Sitbon talks about “Optimizing treatment in patients with...
BY WENDY HENDERSON Lupus Lupus is an autoimmune disease that can attack any part of the body causing inflammation, including the lungs. While it hasn’t yet been established if lupus is a cause of pulmonary hypertension, the two diseases can...
Pulmonary hypertension (PH) is a rare, life-threatening disease that affects the pulmonary arteries, the lungs, and the heart. Patients who suffer from the disease have narrow and obstructed pulmonary arteries — the vessels responsible for transporting blood from the heart to the...
By MAGDALENA KEGEL Blocking the enzyme sphingosine kinase 1 (SK1) reduced right ventricle enlargement in a mouse model of pulmonary arterial hypertension (PAH), while having no impact on blood vessel remodeling. The findings, published in the journalCellular Signalling, highlighted disease...
By Patricia Inacio, PhD Galectin-3 (Gal-3) and the hormone aldosterone are two potentialbiomarkers for disease progression in patients with pulmonary arterial hypertension, according to a recent study, “Galectin-3 and aldosterone as potential tandem biomarkers in pulmonary arterial hypertension,” published in the journal...
By DANIELA SEMEDO, PHD Work on a doctoral dissertation at Umeå University in Sweden led to the discovery of new blood biomarkers reflecting vasoreactivity in lung blood vessels of patients with heart and lung disease, which can lead to simplified diagnostics and better...
BY MAGDALENA KEGEL Right ventricular dysfunction is intimately linked to pulmonary hypertension (PH). Since the dynamics of the two ventricles of the heart are connected through the shared tissue of the septum – the wall between the two ventricles – the team behind...
By MALIKA AMMAM, PHD A recent study suggests that RNA fragments called microRNAs (miRNAs), long thought of as genetic “junk,” actually control the production of endothelial cells, whose over-proliferation is responsible for the development of pulmonary hypertension (PH). The study, published in the Experimental Biology...
BY MARGARIDA AZEVEDO Over the last decade, new oral therapy agents in the form of pills used for the management and treatment of pulmonary arterial hypertension (PAH) have been integrated and improved, such as ERAs, PDE-5 inhibitors, and prostacyclin...